Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Emergence Delirium × Ropivacaine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pain, Postoperative 16 Breast Neoplasms 15 Pain 9 Agnosia 6 Prostatic Neoplasms 5 Lung Neoplasms 5 Neoplasms 4 Stomach Neoplasms 3 Postoperative Complications 3 Supratentorial Neoplasms 2 Colorectal Neoplasms 2 Colonic Neoplasms 2 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Thyroid Neoplasms 1 Sleep Deprivation 1 Sarcoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pancreatic Neoplasms 1 Pancreatic Ductal Adenocarcinoma 1 Pain, Intractable 1 Ovarian Neoplasms 1 Ovarian Cysts 1 Oropharyngeal Neoplasms 1 Neuroblastoma 1 Neoplasm Metastasis 1 Meningioma 1 Malignant Neoplasms of Male Genital Organs 1 Liver Neoplasms 1 Liver Diseases 1

Interventions

Saline Solution 3 Propofol 3 Dexmedetomidine 3 remimazolam 2 Sugammadex 1 Sufentanil 1 Spectroscopy, Near-Infrared 1 Sodium Chloride 1 Ropivacaine 1 Pyridostigmine Bromide 1 Neuroleptanalgesia 1 Nalbuphine 1 Minocycline 1 Midazolam 1 Methylene Blue 1 Ketamine 1 Injections 1 Ibuprofen 1 Duloxetine Hydrochloride 1 Blood Specimen Collection 1 Acetaminophen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05596071 2022-10-27

POD

Zhejiang Cancer Hospital

Phase NA Completed

Gastrointestinal

Emergence Delirium, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡